ImClone Systems Biopharmaceutical Plant, Branchburg, NJ, USA
Key Data:
Order Year
2004
Project Type
Plant expansion
Location
Branchburg, New Jersey, US
Estimated Investment
$260m
Completion
2006
Key Players:
Sponsor
ImClone Systems, Inc
Lead Contractor
Kvaerner, Binskey and Snyder, Vicataulic, Midwest Mechanical Contractors
Output Chemicals:
Cancer Therapeutic
Erbitux commercially and other pipeline drugs for investigational quantities
